Merck-Controlled Joint Venture With Simcere Opens Before Schedule
This article was originally published in PharmAsia News
Executive Summary
Simcere MSD (Shanghai) Pharmaceutical Co. Ltd., 51% owned by Merck & Co. Inc. and 49% by Simcere Pharmaceutical Group, began operations Sep. 12, originally scheduled for 2013.